Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Keating

Showing results (941-950 of 1,115) with videos related to

Pageof 112
Sort By:
Journal of the National Cancer Institute|December 8, 2005
OSW-1: a natural compound with potent anticancer activity and a novel mechanism of actionYan Zhou, Celia Garcia-Prieto, Dennis A Carney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation FailureUri Rozovski, Ohad Benjamini, Preetesh Jain, et al.
Cancer|March 26, 2003
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemiaApostolia M Tsimberidou, Hagop M Kantarjian, Jorge Cortes, et al.
Cancer Immunology Research|September 19, 2019
Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic LeukemiaPriyanka Banerjee, Ronghua Zhang, Cristina Ivan, et al.
The Journal of Molecular Diagnostics : JMD|January 1, 2013
Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypesCarmen D Schweighofer, Kevin R Coombes, Tadeusz Majewski, et al.
Molecular Cancer|June 4, 2013
Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cellsUri Rozovski, George A Calin, Tetsuro Setoyama, et al.
Transplantation|February 26, 2019
Genetic Variants Associated With Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome-wide Association StudiesWilliam S Oetting, Baolin Wu, David P Schladt, et al.
Nature Medicine|November 22, 2016
Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growthShira L Cramer, Achinto Saha, Jinyun Liu, et al.
Plos One|January 4, 2013
Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APCWilliam K Decker, Nina Shah, Dongxia Xing, et al.
Leukemia|May 24, 2003
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapyA-M Tsimberidou, H M Kantarjian, E Estey, et al.
Pageof 112

Showing results (941-950 of 1,115) with videos related to

Sort By:
Pageof 112
Journal of the National Cancer Institute|December 8, 2005
OSW-1: a natural compound with potent anticancer activity and a novel mechanism of actionYan Zhou, Celia Garcia-Prieto, Dennis A Carney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation FailureUri Rozovski, Ohad Benjamini, Preetesh Jain, et al.
Cancer|March 26, 2003
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemiaApostolia M Tsimberidou, Hagop M Kantarjian, Jorge Cortes, et al.
Cancer Immunology Research|September 19, 2019
Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic LeukemiaPriyanka Banerjee, Ronghua Zhang, Cristina Ivan, et al.
The Journal of Molecular Diagnostics : JMD|January 1, 2013
Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypesCarmen D Schweighofer, Kevin R Coombes, Tadeusz Majewski, et al.
Molecular Cancer|June 4, 2013
Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cellsUri Rozovski, George A Calin, Tetsuro Setoyama, et al.
Transplantation|February 26, 2019
Genetic Variants Associated With Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome-wide Association StudiesWilliam S Oetting, Baolin Wu, David P Schladt, et al.
Nature Medicine|November 22, 2016
Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growthShira L Cramer, Achinto Saha, Jinyun Liu, et al.
Plos One|January 4, 2013
Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APCWilliam K Decker, Nina Shah, Dongxia Xing, et al.
Leukemia|May 24, 2003
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapyA-M Tsimberidou, H M Kantarjian, E Estey, et al.
Pageof 112